Gritstone Oncology, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.75
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.40
|
-0.35
|
0.05
|
12.50%
|
|
2022-06-30
|
-0.40
|
-0.34
|
0.06
|
15.00%
|
|
2022-03-31
|
-0.37
|
-0.34
|
0.03
|
8.11%
|
|
2021-12-31
|
-0.38
|
-0.37
|
0.01
|
2.63%
|
|
2021-09-30
|
-0.52
|
-0.36
|
0.16
|
30.77%
|
|
2021-06-30
|
-0.58
|
-0.33
|
0.25
|
43.10%
|
|
2021-03-31
|
-0.39
|
0.10
|
0.49
|
125.64%
|
|
2020-12-31
|
-0.61
|
-0.69
|
-0.08
|
-13.11%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.03
|
|
2021-12-31
|
-0.96
|
|
2020-12-31
|
-2.78
|
|
2019-12-31
|
-2.79
|
|
2018-12-31
|
-8.91
|